Physician profile
Gregory I Gordon
NPI 1205804267
$117,435.19
in general payments reported to CMS, 2019-2025
12 companies · $59.77 in 2025
The $59.77 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.03 · 2020: $103K · 2021: $334 · 2022: $7,088 · 2023: $6,164 · 2024: $257 · 2025: $59.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,958 · Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,958.34 |
| Food and Beverage | $521.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radux Devices LLC | $103,357.00 | 2020 | |
| Angiodynamics, INC. | $12,916.67 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $377.55 | 2020-2025 | Opticross 35, Intracept, Jetstream Sc |
| Medtronic, INC. | $377.32 | 2021-2023 | Ellipsys Vascular Access System, Chameleon |
| Healthtronics Stone Solutions, LLC | $133.47 | 2020-2021 | |
| Inari Medical, INC. | $111.44 | 2022 | |
| Bard Peripheral Vascular, INC. | $37.18 | 2019 | |
| Conetic Solutions, INC. | $31.26 | 2021 | |
| Sirtex Medical INC | $30.35 | 2019 | |
| Terumo Medical Corporation | $25.40 | 2020-2021 | |
| Varian Medical Systems, INC. | $24.05 | 2020 | |
| Penumbra, INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,117,932.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.